New Born Free USA Report Reveals the Suffering of Giraffe in Zoos June 15, 2022 7:00 am|Leading animal welfare organization calls for phase-out of keeping these complex animals in zoo captivity
Enchanted Rock to Develop California's Largest Renewable Microgrid to Ensure Resiliency of Microsoft Data Center June 15, 2022 7:00 am|The project will be fully supported by renewable natural gas and will reduce local emissions by up to…
NOWATCH Raises $8.7 Million Series A Round Led by Angel Investor Chris Hall June 15, 2022 7:00 am|Investment to solidify lead in new total health ”awareable’ category
CYBELLUM ANNOUNCES RELEASE OF “SYSTEM OF SYSTEMS” PROVIDING UNPRECEDENTED VISIBILITY AND CONTROL FOR PRODUCT SECURITY TEAMS June 15, 2022 7:00 am|Enables security management of a complete vehicle or product system, through a unified assessment of all its underlying…
Marengo Therapeutics Expands Executive Leadership Team with Svetlana Makhni Joining as Chief Financial Officer June 15, 2022 7:00 am|CAMBRIDGE, Mass., June 15, 2022 /PRNewswire/ — Marengo Therapeutics, Inc., a company pioneering novel therapeutics that directly target…
Priceline Makes Travel Easy And Affordable With Summer Sale And Expanded Loyalty Program June 15, 2022 7:00 am|Priceline offers more ways to save as consumers gear up for what’s expected to be a record travel…
Detect Gunshots, Fights, and Keywords with Smart Audio Capabilities– Rhombus Systems Releases Intelligent Audio Gateway with Two-Way Communication June 15, 2022 7:00 am|SACRAMENTO, Calif., June 15, 2022 /PRNewswire/ — Rhombus Systems, a leader in enterprise cloud-managed security cameras and sensors,…
PayPal Introduces 'Pay Monthly' to Give Consumers More Choice at Checkout June 15, 2022 7:00 am|Expansion of ‘Buy Now Pay Later’ product suite offers new flexible monthly payments with no late fees in…
Planet Smoothie Supports Alex's Lemonade Stand Foundation on National Smoothie Day June 15, 2022 7:00 am|SCOTTSDALE, Ariz., June 15, 2022 /PRNewswire/ — Planet Smoothie® (www.PlanetSmoothie.com) is celebrating National Smoothie Day on Tuesday, June…
Kymera Therapeutics Doses First Patients in Phase 1 Oncology Trials of STAT3 and IRAKIMiD Degraders KT-333 and KT-413 June 15, 2022 7:00 am|KT-333 is a first-in-class heterobifunctional degrader of the transcriptional regulator STAT3 in development for T cell malignancies and…